Objective: To investigate the effect and mechanisms of Fuzheng huayu formula (FZHY) on biliary fibrosis in mice. Methods: Mdr2 gene knowout (Mdr2-/-) mice were randomly divided into model group, FZHY-treated group and obeticholic acid (OCA)-treated group. Wide type C57BL/6J (WT) mice of the same age were used as the control group. Mdr2-/- mice were treated with the corresponding drugs by gavage from the first day of the 9th week old. The WT and model groups were given 0.3% sodium carboxymethyl cellulose by gavage, and the mice were sacrificed at the end of 12th week old. The activities of serum alkaline phosphatase (ALP) and alanine aminotransferase (ALT) were detected by high-speed biochemical analyzer. H&E staining and sirius red staining were used to observe the pathological changes of liver tissues. The hepatic hydroxyproline content was determined. The hepatic expressions of Col-Ⅰ and α-SMA, ductular reaction markers Epcam, CK7, CK19, and the expression of Pcna, Mki67 and Ccnd1; as well as the expression of inflammatory cytokines Ccl2, Ccl5, Tnf-α, Il10 and Cxcl4 were detected by immunohistochemical staining, western blot and qRT-PCR, respectively. Furthermore, the expression of PPARα and the phosphorylation NF-κB were detected by western blot. Results: Compared with WT mice, the serum ALT and ALP activities of Mdr2-/- mice were significantly increased (P<0.001). The percentage of SR positive stained area and hepatic Hyp content were significantly increased (P<0.01). The hepatic expression of Col-Ⅰ and α-SMA; Epcam, CK7, CK19, Pcna, Mki67 and Ccnd1; Ccl2, Ccl5, Tnf-α, Il10 and Cxcl4 were significantly increased (P<0.01). However, both FZHY and OCA significantly reversed the elevation of these aforementioned indicators (P<0.05; P<0.01). Further study showed that the hepatic expression of PPARα in Mdr2-/- mice was significantly lower than that of WT mice, however the phosphorylation of NF-κB was significantly enhanced (P<0.01). The expression of PPARα in liver tissues of FZHY mice was significantly increased (P<0.05), and the NF-κB phosphorylation was significantly inhibited compared with Mdr2-/- mice (P<0.05). Conclusion: FZHY significantly ameliorated liver fibrosis, ductular reaction and inflammation in Mdr2-/- spontaneous biliary fibrosis mice, and its mechanism was related to the regulation of PPARα/NF-κB pathway.
目的: 探讨扶正化瘀方(FZHY)对小鼠胆汁淤积性肝纤维化的干预作用及其部分效应机制。 方法: 将Mdr2基因敲除(Mdr2-/-)小鼠随机分为模型组、FZHY组、奥贝胆酸组。同周龄野生型C57BL/6J小鼠作为对照组。Mdr2-/-小鼠9周龄首日起,各用药组予以相应药物灌胃;对照组和模型组予0.3%羧甲基纤维素钠灌胃,12周龄末处死取材。高速生物化学分析仪检测小鼠血清碱性磷酸酶和丙氨酸氨基转移酶活性;苏木精-伊红染色、天狼猩红染色法观察肝组织病理变化;羟脯氨酸含量测定法检测肝组织胶原情况;免疫组织化学染色,蛋白免疫印迹法、实时荧光定量聚合酶链式反应法分别检测肝组织纤维化指标Col-Ⅰ和α-平滑肌肌动蛋白的表达;胆管反应标志物Epcam、CK7和CK19以及Pcna、Mki67和Ccnd1的表达;炎症相关因子Ccl2、Ccl5、Tnf-α、Il10和Cxcl4的表达;以及过氧化物酶体增殖物激活受体(PPAR)α和核因子(NF)-κB磷酸化的表达情况。多组间比较采用单因素方差分析;组间比较采用LSD法。采用双侧统计检验。 结果: 与野生型小鼠比较,Mdr2-/-小鼠血清丙氨酸氨基转移酶和碱性磷酸酶活性显著升高(P<0.001);肝组织天狼猩红阳性染色面积百分比和羟脯氨酸含量显著升高(P<0.01);肝组织Col-Ⅰ、α-平滑肌肌动蛋白;Epcam、CK7、CK19、Pcna、Mki67和Ccnd1的表达;Ccl2、Ccl5、Tnf-α、Il10和Cxcl4的表达显著增加(P<0.01);而FZHY和奥贝胆酸干预后均能显著逆转这些指标的升高(P<0.05;P<0.01)。进一步研究结果显示,与野生型小鼠比较,Mdr2-/-小鼠肝组织PPARα的表达显著降低;NF-κB磷酸化显著增强(P<0.01);而与Mdr2-/-小鼠比较,FZHY组小鼠肝组织PPARα的表达显著增加(P<0.05);NF-κB磷酸化被显著抑制(P<0.05)。 结论: FZHY可显著改善Mdr2-/-自发性胆汁淤积性肝纤维化小鼠肝脏的纤维化、胆管反应和炎症,其作用机制与调控PPARα/NF-κB通路有关。.